Skip to Main Content

Paper Details

Development, formulation, and cellular mechanism of a lipophilic copper chelator for the treatment of Wilson's disease.
International Journal of Pharmaceutics
4
2021
ATP7B copper transporter, Copper, Cu, Cu(I), Wilson's disease, bile, copper, copper accumulation, hepatocytes, human, nanolipid
Author NameAffiliation
Laura GauthierUniversity Grenoble Alpes, CNRS, France University Grenoble Alpes
  • 1 - 1

Datasets

Release 1.2